SCHEMBL10740928

SCHEMBL10740928

CCOc1cccc(-c2nc3nccnc3[nH]2)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AURKA O14965 2/20 0.52
FGFR1 P11362 1/20 0.49
FGFR2 P21802 1/20 0.49
FGFR3 P22607 1/20 0.49
GSK3B P49841 3/20 0.47
MAPT P10636 3/20 0.47
TP53 P04637 3/20 0.47
KDM4E B2RXH2 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
NPC1 O15118 1/20 0.47
USP2 O75604 1/20 0.47
ALDH1A1 P00352 1/20 0.47
LMNA P02545 1/20 0.47
HPGD P15428 1/20 0.47
TSHR P16473 1/20 0.47
NFKB1 P19838 1/20 0.47
RAB9A P51151 1/20 0.47
NFKB2 Q00653 1/20 0.47
RELA Q04206 1/20 0.47
HSD17B10 Q99714 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10739361 0.90 AURKA (0.50) AURKAGSK3BMAPTTP53KDM4E
SCHEMBL10741718 0.86 AURKA (0.69) AURKAGSK3BCCNB2CDK1CCNB1
SCHEMBL10735812 0.83 MAOB (0.52) AURKAGSK3BMETAP2METAP1CCNB2
SCHEMBL10738562 0.83 AURKA (0.46) AURKAGSK3BKDM4ESMN1; SMN2NPC1
SCHEMBL10736622 0.83 AURKA (0.46) AURKAFGFR1FGFR2FGFR3GSK3B
SCHEMBL10737285 0.83 TBK1 (0.53) AURKAMAPTTP53KDM4ESMN1; SMN2
SCHEMBL10743321 0.77 AURKA (0.55) AURKAGSK3BKDM4ESMN1; SMN2NPC1
SCHEMBL10735410 0.77 PDE5A (0.48) MAPTTP53KDM4ESMN1; SMN2NPC1
SCHEMBL10740241 0.77 MEN1 (0.43) MAPTTP53KDM4ESMN1; SMN2USP2
SCHEMBL10742341 0.77 METAP2 (0.43) AURKAGSK3BMAPTKDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4654344-A ALSO AFFECT BLOOD PRESSURE AND MYOCARDIAL CONTRACTIONS MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1987-03-31 US disclosed
EP-0093951-B1 2-ARYL-TETRAAZAINDENES MERCK PATENT GmbH (DE) 1986-10-29 EP disclosed
US-4575505-A Pharmaceutical compositions containing 2-aryltetraazaindenes for treating ulcers or cardiac insufficiency or blood pressure abnormalities MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1986-03-11 US disclosed
US-4477454-A INDOTROPIC AGENTS MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1984-10-16 US disclosed
EP-0093951-A2 2-Aryl-tetraazaindenes MERCK PATENT GmbH (DE) 1983-11-16 EP disclosed